The Cubs have been extremely active on the trade market over the past week, but it seems their latest deal may have hit a snag. Bruce Levine of 670 The Score said on air this morning that Chicago’s talks for Marlins lefty Jesus Luzardo “appear to be dead” after having some serious momentum earlier in the week (audio link, Luzardo talk around the 2:13:45 mark). It’s not entirely clear whether the parties will seek to rekindle negotiations, but Levine suggests that medical reviews on one side or the other could have thrown a wrench into talks.
The natural inclination for many will be to presume that Luzardo’s medical records proved to be the hitch, but there’s no firm indication that’s the case. It’s every bit as possible that the Marlins took a look at medical records on one of the prospects who was a focal point in the proposed return and balked at what they saw.
Luzardo, 27, has repeatedly demonstrated front-of-the-rotation potential but hasn’t been able to consistently deliver results at that level — often due to injuries. He posted a 3.48 ERA with an excellent 28.7% strikeout rate against a sharp 7.9% walk rate in 279 innings from 2022-23 but missed time along the way due to a forearm strain. Luzardo, who had Tommy John surgery as a prospect, also spent time on the injured list early in 2024 due to elbow tightness. He returned and pitched well — 3.98 ERA over his next seven starts — only to land back on the injured list in mid-June with a lumbar stress reaction that wound up ending his season.
Luzardo has only reached 100 big league innings twice in his career and has only started more than 18 games in the majors once. Including minor league work, he topped 100 innings each year from 2021-23, but those are his only professional seasons doing so. His 178 2/3 innings from 2023 are far and away a career-high mark.
Durability concerns notwithstanding, prime-aged lefties who average around 96 mph on their heater while boasting plus swinging-strike and strikeout rates alike are rare. Add Luzardo’s at least average command into the mix, and the potential for him to emerge as a bona fide star is clear. He was a top-100 draft pick and one of the top pitching prospects in baseball prior to his debut, after all. However, keeping him healthy has been a difficult task for the A’s and Marlins alike.
Even if it was Luzardo’s medicals that held up a potential deal — and again, we decidedly do not know that to be the case — that doesn’t eliminate the possibility of a trade sending him elsewhere. We’ve seen plenty of past instances where one team backs out of a deal based on a player’s medicals while another club finds them acceptable. For instance, the Yankees reportedly nixed a trade for Jack Flaherty over the summer due to medical concerns. The Dodgers were comfortable enough making a deal and got 10 regular season starts out of Flaherty, plus another five in the postseason. Different teams have different thresholds, and everything that’s taken into consideration is done so relative to the valuation of the players going the other direction in the deal.
As for the Cubs and what might be next if the Luzardo talks can’t be revived — that’s an open question. The trade of Cody Bellinger trimmed $25MM of his $27.5MM salary from the books, giving Chicago plenty of flexibility. RosterResource estimates their current payroll to be around $174MM, with just over $191MM of luxury obligations. That puts the Cubs roughly $50MM shy of the first luxury threshold. At least on paper, that leaves room to add virtually any free agent without needing to worry about the luxury tax, though Levine pushes back strongly on the idea of Chicago making a run at Corbin Burnes.
There’s a clear need for bullpen help and a strong likelihood that the Cubs will jump into the market for some notable late-inning options. History suggests that president of baseball operations Jed Hoyer will prefer to keep any free agent commitments there to the short-term variety. Hoyer has not given out a multi-year deal to a reliever since taking over baseball operations in Chicago. Kirby Yates, old friend David Robertson and Kenley Jansen are among the older but still-effective closing options who could be had on short-term deals. If the Cubs are willing to break from their past behavior on the relief market and pursue larger-scale targets, then names like Tanner Scott, Jeff Hoffman and Carlos Estevez currently top the market.